IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ALBERICI, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.115
AS - Asia 3.481
EU - Europa 2.216
SA - Sud America 827
Continente sconosciuto - Info sul continente non disponibili 177
AF - Africa 93
OC - Oceania 13
Totale 12.922
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.849
SG - Singapore 1.248
CN - Cina 790
IT - Italia 754
BR - Brasile 686
HK - Hong Kong 476
VN - Vietnam 290
DE - Germania 248
UA - Ucraina 239
BD - Bangladesh 236
GB - Regno Unito 218
RU - Federazione Russa 150
FR - Francia 149
TR - Turchia 141
CA - Canada 135
FI - Finlandia 111
IE - Irlanda 82
IN - India 81
PL - Polonia 61
AR - Argentina 56
MX - Messico 44
NL - Olanda 41
IQ - Iraq 34
JP - Giappone 31
ID - Indonesia 27
ZA - Sudafrica 24
AT - Austria 23
EC - Ecuador 21
SA - Arabia Saudita 21
CO - Colombia 20
SE - Svezia 20
DZ - Algeria 18
CZ - Repubblica Ceca 16
ES - Italia 16
JM - Giamaica 16
CR - Costa Rica 15
EG - Egitto 14
MA - Marocco 14
PY - Paraguay 13
BE - Belgio 12
TT - Trinidad e Tobago 12
LT - Lituania 10
PK - Pakistan 10
UZ - Uzbekistan 10
AU - Australia 9
CL - Cile 9
EE - Estonia 9
EU - Europa 9
GT - Guatemala 9
HN - Honduras 8
PH - Filippine 8
PT - Portogallo 8
IL - Israele 7
IR - Iran 7
KZ - Kazakistan 7
MY - Malesia 7
PR - Porto Rico 7
TH - Thailandia 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
KE - Kenya 6
PE - Perù 6
RO - Romania 6
TN - Tunisia 6
UY - Uruguay 6
AL - Albania 5
AZ - Azerbaigian 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
RS - Serbia 5
GY - Guiana 4
HU - Ungheria 4
JO - Giordania 4
NO - Norvegia 4
VE - Venezuela 4
BS - Bahamas 3
CW - ???statistics.table.value.countryCode.CW??? 3
LB - Libano 3
LV - Lettonia 3
NP - Nepal 3
PA - Panama 3
SC - Seychelles 3
AM - Armenia 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
ET - Etiopia 2
HR - Croazia 2
KR - Corea 2
LU - Lussemburgo 2
MM - Myanmar 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
OM - Oman 2
QA - Qatar 2
SV - El Salvador 2
SX - ???statistics.table.value.countryCode.SX??? 2
Totale 12.740
Salva come PNG Salva come JPEG
Città #
Ashburn 672
Singapore 606
Hong Kong 473
San Jose 452
Fairfield 420
Council Bluffs 275
The Dalles 246
Woodbridge 226
Beijing 221
Houston 198
Seattle 178
Jacksonville 177
New York 161
Wilmington 156
Cambridge 153
Princeton 147
Los Angeles 140
Lauterbourg 119
Dallas 112
Istanbul 98
Ho Chi Minh City 96
Helsinki 84
Columbus 80
Dublin 79
Chandler 72
Hanoi 72
Ann Arbor 70
São Paulo 67
Santa Clara 63
Chicago 61
Milan 60
Buffalo 55
Munich 53
Warsaw 53
Brescia 49
Moscow 48
San Diego 42
Rome 41
Redondo Beach 40
Phoenix 39
Nuremberg 35
Des Moines 33
Shanghai 33
Montreal 32
North Bergen 32
Toronto 32
Frankfurt am Main 31
Denver 29
London 29
San Francisco 28
Orem 26
Bologna 24
Atlanta 22
Chennai 22
Florence 22
Tokyo 22
Turku 21
Brooklyn 20
Romola 20
Washington 18
Rio de Janeiro 17
Las Vegas 16
Meram 16
Naples 16
Mexico City 15
Dhaka 14
Tianjin 14
Boston 13
Brasília 13
Brno 13
Düsseldorf 13
Philadelphia 13
Algiers 12
Belo Horizonte 12
Miano 12
San José 12
Baghdad 11
Charlotte 11
Curitiba 11
Haiphong 11
Kocaeli 11
Quito 11
Stockholm 11
Amsterdam 10
Brussels 10
Catania 10
Changsha 10
Jinan 10
Kingston 10
Nereto 10
Campinas 9
Miami 9
Vienna 9
Boardman 8
Buenos Aires 8
Goiânia 8
Guatemala City 8
Jeddah 8
Johannesburg 8
Manchester 8
Totale 7.436
Salva come PNG Salva come JPEG
Nome #
Nonlupus Full House Nephropathy 186
A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection 183
Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody–associated vasculitis 179
Changes in 24-hour blood pressure profile after 12 weeks of dapagliflozin treatment in patients with diabetic kidney disease: An Italian multicenter prospective study 171
Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): A phase III, randomized, multicentre trial of the italian oncology group for clinical research (GOIRC) 170
Genetics of ANCA-Associated Vasculitis 161
Cluster analysis identifies distinct pathogenetic patterns in c3 glomerulopathies/immune complex–Mediated membranoproliferative GN 161
Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy 160
Sustained post-rituximab B cell depletion is common in ANCA-associated Vasculitis and affected by sex and renal function 144
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 144
SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response 143
A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia 142
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study 142
Sirolimus plus prednisone for Erdheim-Chester disease: An open-label trial 139
Kidney transplant patients with SARS-CoV-2 infection: The Brescia Renal COVID task force experience 138
A cross-sectional study of the Birmingham vasculitis activity score version 3 in systemic vasculitis 136
Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis 135
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 131
[Infection-related glomerulonephritis: the new face of an old disease] 131
Pneumocystis Jirevocii and SARS-CoV-2 co-infection: A common feature in transplant recipients? 128
[Glomerulonefriti da tossici e farmaci] 128
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 126
[Managing patients in dialysis and with kidney transplant infected with Covid-19] 124
Role of chemotherapy with gemcitabine plus 5-fluorouracil and chemoimmunotherapy in metastatic renal cell cancer (mRCC) 122
Lupus nephritis and B-cell targeting therapy 119
The safety of corticosteroid therapy in IGA nephropathy: analysis of a real-life Italian cohort 118
[The complex etiopathogenesis of focal segmental glomerulosclerosis] 118
Chronically administered immunotherapy with low-dose IL-2 and IFN-α in metastatic renal cell carcinoma: A feasible option for patients with a good prognostic profile 115
Chronic periaortitis with thoracic aorta and epiaortic artery involvement: A systemic large vessel vasculitis? 115
Update on ANCA-associated vasculitis: from biomarkers to therapy 115
Monoallelic pathogenic IFT140 variants are a common cause of autosomal dominant polycystic kidney disease–spectrum phenotype 114
Avacopan for the treatment of ANCA-associated vasculitis 114
[Peritoneal dialysis: what have we learned from the Covid-19 pandemic?] 113
Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: An open-label randomised controlled trial 111
PTPN22 R620W polymorphism in the ANCA-associated vasculitides 111
[ADPKD and intracranial aneurysms: indications for screening, follow-up and clinical management] 111
Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: A case series 109
Orofacial granulomatosis treated with low-level laser therapy: A case report 108
Impact of rituximab trials on the treatment of ANCA-associated vasculitis 108
The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 106
An Initial Low-Dose Etelcalcetide Dosing Strategy in Hemodialysis Patients With Moderate Secondary Hyperparathyroidism is Effective and Cost-Saving 105
IgG4 immune response in Churg-Strauss syndrome 105
Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease 105
Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis 104
Lessons From the Clinic: ADPKD Genetic Test Unraveling Severe Phenotype, Intrafamilial Variability, and New, Rare Causing Genotype 104
The role of analytical methods for the determination of trace elements in environmental biomonitors 103
Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis 102
Natural killer cell cytotoxicity is enhanced by very low doses of rIL-2 and rIFN-α in patients with renal cell carcinoma 102
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 101
Measurement of damage in systemic vasculitis: A comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index 101
Prevention of arterial thrombosis recurrence in anti-phospholipid syndrome: are anti-platelets the answer? 101
Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study. 101
Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination 100
Magnetic resonance imaging in central nervous system vasculitis in a patient affected by crioglobulin-negative hepatitis C virus infection: A likely correlation 100
Peripheral inflammatory arthritis in patients with chronic periaortitis: Report of five cases and review of the literature 100
Hemodialysis techniques and outcomes in patients with COVID-19: The Brescia experience 99
FCGR2A single nucleotide polymorphism confers susceptibility to childhood-onset idiopathic nephrotic syndrome 99
Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis 98
The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult 97
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 97
Chronic periaortitis associated with membranous nephropathy: Clues to common pathogenetic mechanisms 97
Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial 96
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) 96
Autosomal Dominant Tubulointerstitial Kidney Disease: An Emerging Cause of Genetic CKD 95
Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies 95
Genetics of ANCA-associated vasculitides: HLA and beyond 95
Clinical Significance of the Cystic Phenotype in Alport Syndrome 95
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial 94
Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients 93
Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis 92
Expanding the variability of the ADPKD-GANAB clinical phenotype in a family of Italian ancestry 91
Association of a polymorphism of the Fc gamma-receptor 2A (FCGR2A) gene with chronic periaortitis 89
The Authors Reply 89
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial 88
Treatment of secondary hyperparathyroidism in hemodialysis patients: a comparison between two Italian centers to evaluate real-world guideline implementation 87
Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis 86
Safety and Efficacy of Avacopan in Patients with Complement 3 Glomerulopathy 86
FCGR3B polymorphism predicts relapse risk in eosinophilic granulomatosis with polyangiitis 86
[State of art and new perspectives in the induction regimen of ANCA-associated vasculitis with renal involvement: from histopathology to therapy] 86
Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study 85
Correspondence on 'Immunogenicity and safety of anti-SARS-Cov-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort' 83
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 82
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy 82
Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International Study 81
Treatment goals in ANCA-associated vasculitis: defining success in a new era 80
Variable Expressivity of HNF1B Nephropathy From Renal Cysts and Diabetes to Medullary Sponge Kidney Through Tubulo-interstitial Kidney Disease 80
[Anti-SARS-CoV-2 vaccination in patients with immune-mediated kidney diseases. Recommendations of the Italian Society on Nephrology's Working Group on Renal Immunopathology (Vaccine Task Force)] 80
Rituximab in Membranous Nephropathy 79
Therapies for Membranous Nephropathy: A Tale From the Old and New Millennia 79
From prevention to treatment: Comprehensive strategies for the management of Staphylococcus aureus induced catheter-related bloodstream infections 77
Peritoneal dialysis discontinuation: to the root of the problem 76
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown? 76
Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis 75
Galileo—an Artificial Intelligence tool for evaluating pre-implantation kidney biopsies 75
Machine Learning for Monoclonal Gammopathies of Renal Significance Risk Stratification Using Clinical and Pathology Data 73
COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab 73
Editorial: “Toward Precision Medicine in Vasculitis” 72
Occupational Exposures and Smoking in Eosinophilic Granulomatosis With Polyangiitis: A Case–Control Study 70
The ideal marker for measuring GFR: what are we looking for? 69
Sodium-Glucose Cotransporter-2–inhibitors in Adult Patients With Alport Syndrome 67
Totale 10.703
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.725
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.725
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022430 0 0 0 18 2 64 28 36 37 58 37 150
2022/2023373 83 2 7 7 20 114 0 30 48 2 28 32
2023/2024811 32 30 29 63 53 111 28 34 236 11 26 158
2024/20251.998 8 26 42 236 150 153 199 85 209 277 397 216
2025/20264.907 338 603 412 743 387 273 599 213 306 486 340 207
2026/20272.039 290 337 458 954 0 0 0 0 0 0 0 0
Totale 12.922